Download PDF
Hamostaseologie 2019; 39(04): 355-359
DOI: 10.1055/s-0039-1677874
Original Article
Georg Thieme Verlag KG Stuttgart · New York

Prevalence of Obesity in Young Patients with Severe Haemophilia and Its Potential Impact on Factor VIII Consumption in Germany

Martin Olivieri
1   Paediatric Haemophilia Centre, Dr. von Hauner Children's Hospital, LMU Munich, Munich, Germany
,
Christoph Königs
2   Department of Paediatrics, Paediatric Haemophilia Centre, Goethe University, University Hospital Frankfurt, Frankfurt, Germany
,
Christine Heller
2   Department of Paediatrics, Paediatric Haemophilia Centre, Goethe University, University Hospital Frankfurt, Frankfurt, Germany
,
Silvia Horneff
3   Institute of Experimental Haematology and Transfusion Medicine, University Clinic Bonn, Bonn, Germany
,
Johannes Oldenburg
3   Institute of Experimental Haematology and Transfusion Medicine, University Clinic Bonn, Bonn, Germany
,
Susan Halimeh
4   Coagulation Centre Rhine-Ruhr, Medical Thrombosis and Haemophilia Treatment Centre and Specialized Laboratory for Coagulation Disorders/Haemophilia, Duisburg, Germany
,
Karim Kentouche
5   Department of Paediatric Haematology and Oncology, University Hospital for Children and Adolescents, Friedrich Schiller University, Jena, Germany
,
Ralf Knöfler
6   Department of Paediatric Haemostaseology, University Hospital ‘Carl Gustav Carus’, Technical University, Dresden, Germany
,
Lars Fischer
7   Department of Paediatric Haematology, Oncology and Haemostaseology, University Childrens Hospital Leipzig, Leipzig, Germany
,
Christian Pfrepper
8   Centre for Haemostaseology, University Hospital Leipzig, Leipzig, Germany
,
Karin Kurnik
1   Paediatric Haemophilia Centre, Dr. von Hauner Children's Hospital, LMU Munich, Munich, Germany
,
Christoph Bidlingmaier
1   Paediatric Haemophilia Centre, Dr. von Hauner Children's Hospital, LMU Munich, Munich, Germany
› Author Affiliations
Further Information

Publication History

31 March 2018

23 December 2018

Publication Date:
05 February 2019 (online)

Also available at
    Permissions and Reprints

Abstract

Similar to the general population, overweight and obesity have increasingly become a medical and economic burden also in patients with haemophilia in industrialized nations. In this study in seven German haemophilia centres, we identified a prevalence of overweight and obesity of 25.2% among 254 young patients <30 years (median: 13 years; range: 0–30 years) with severe haemophilia A and without a history of inhibitors. The median FVIII dosage based on bodyweight was significantly higher in normal weight compared with overweight or obese patients (96.9 vs. 72.9 IU/kg/week, respectively; p < 0.0001). This suggests that an individualized dosing regime which might be based on FVIII pharmacokinetics, physical activity and pre-existing haemophilic arthropathy is applied rather than dosing by bodyweight only. The bleeding rates observed in obese (median: 1; range: 0–17) versus normal weight patients (median: 2; range: 0–28) did not differ significantly (p = 0.057). Lower bleeding rates might be due to reduced activity or expected higher FVIII plasma levels in overweight patients. Due to the increasing prevalence of overweight/obesity in patients with haemophilia an interdisciplinary approach for individualized haemophilia treatment and weight loss programmes might be helpful for optimal and economical treatment for this group of patients.

Zusammenfassung

Wie in der allgemeinen Bevölkerung nimmt die Prävalenz von Übergewicht und Adipositas auch bei Patienten mit Hämophilie zu. Für die vorliegende Studie wurden in 7 deutschen Hämophiliezentren 254 Patienten unter 30 Jahren mit schwerer Hämophilie A und negativer Hemmkörperanamnese erfasst. Das mediane Alter der Patienten lag bei 13 Jahren (0–30 Jahre). 25.2% der Patienten waren übergewichtig bzw. adipös. Der mediane FVIII Verbrauch lag bei normalgewichtigen Patienten bei 96.9 IE/kg/Woche und war signifikant höher als bei übergewichtigen/adipösen Patienten (72.9 IE/kg/Woche, P <0.0001). Patienten mit Übergewicht zeigten in der Studie zudem einen Trend zu einer niedrigeren jährlichen Blutungsrate (Median 1, Spanne 0–17) als normalgewichtige Patienten (Median 2, Spanne 0–28, p = 0.057). Diese niedrigeren Blutungsraten könnten durch verminderte sportliche Aktivität und vermutlich höhere Faktorspiegel bei übergewichtigen Patienten bedingt sein. Aufgrund der zunehmenden Prävalenz an Übergewicht/Adipositas bei Patienten mit Hämophilie könnten ein interdisziplinärer Ansatz zur individualisierten Hämophiliebehandlung und Programme zur Gewichtsreduktion helfen, Therapiekosten und das Risiko durch Übergewicht bedingter Folgeerkrankungen zu reduzieren.

Keywords

severe haemophilia - overweight - obesity - economic burden - factor VIII consumption

Schlüsselwörter

Hämophilie - Übergewicht - Adipositas - Wirtschaftliche Belastung - Faktor VIII-Verbrauch

Author Contributions

Olivieri M, Bidlingmaier C and Königs C designed the research study, performed the research, analysed the data and wrote and revised the paper. Heller C, Horneff S, Oldenburg J, Halimeh S, Kentouche K, Knöfler R, Fischer L, Pfrepper C and Kurnik K performed data collection, read and revised the paper. All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work.


 

  • References

  • 1 Schienkiewitz ABA, Damerow S, Schaffrath Rosario A. Übergewicht und Adipositas im Kindes- und Jugendalter in Deutschland – Querschnittergebnisse aus KiGGS Welle 2 und Trends. J Health Monitoring 2018; 3 (01) 16-23
    PubMedGoogle Scholar
  • 2 Haslam DW, James WP. Obesity. Lancet 2005; 366 (9492): 1197-1209
    CrossrefPubMedGoogle Scholar
  • 3 Srivastava A, Brewer AK, Mauser-Bunschoten EP. , et al; Treatment Guidelines Working Group on Behalf of The World Federation Of Hemophilia. Guidelines for the management of hemophilia. Haemophilia 2013; 19 (01) e1-e47
    CrossrefPubMedGoogle Scholar
  • 4 Majumdar S, Morris A, Gordon C. , et al. Alarmingly high prevalence of obesity in haemophilia in the state of Mississippi. Haemophilia 2010; 16 (03) 455-459
    PubMedGoogle Scholar
  • 5 Wong TE, Majumdar S, Adams E. , et al; Healthy Weight Working Group. Overweight and obesity in hemophilia: a systematic review of the literature. Am J Prev Med 2011; 41 (06) (Suppl. 04) S369-S375
    CrossrefPubMedGoogle Scholar
  • 6 Kahan S, Cuker A, Kushner RF. , et al. Prevalence and impact of obesity in people with haemophilia: review of literature and expert discussion around implementing weight management guidelines. Haemophilia 2017; 23 (06) 812-820
    CrossrefPubMedGoogle Scholar
  • 7 Soucie JM, Wang C, Siddiqi A, Kulkarni R, Recht M, Konkle BA. ; Hemophilia Treatment Center Network. The longitudinal effect of body adiposity on joint mobility in young males with Haemophilia A. Haemophilia 2011; 17 (02) 196-203
    CrossrefPubMedGoogle Scholar
  • 8 Manco-Johnson MJ, Abshire TC, Shapiro AD. , et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med 2007; 357 (06) 535-544
    CrossrefPubMedGoogle Scholar
  • 9 Biere-Rafi S, Haak BW, Peters M, Gerdes VE, Büller HR, Kamphuisen PW. The impairment in daily life of obese haemophiliacs. Haemophilia 2011; 17 (02) 204-208
    CrossrefPubMedGoogle Scholar
  • 10 Tuinenburg A, Biere-Rafi S, Peters M. , et al. Obesity in haemophilia patients: effect on bleeding frequency, clotting factor concentrate usage, and haemostatic and fibrinolytic parameters. Haemophilia 2013; 19 (05) 744-752
    CrossrefPubMedGoogle Scholar
  • 11 Majumdar S, Ahmad N, Karlson C, Morris A, Iyer R. Does weight reduction in haemophilia lead to a decrease in joint bleeds?. Haemophilia 2012; 18 (03) e82-e84
    CrossrefPubMedGoogle Scholar
  • 12 Henrard S, Hermans C. Impact of being overweight on factor VIII dosing in children with haemophilia A. Haemophilia 2016; 22 (03) 361-367
    CrossrefPubMedGoogle Scholar
  • 13 Graham A, Jaworski K. Pharmacokinetic analysis of anti-hemophilic factor in the obese patient. Haemophilia 2014; 20 (02) 226-229
    CrossrefPubMedGoogle Scholar
  • 14 Fischer K, Ljung R. Primary prophylaxis in haemophilia care: guideline update 2016. Blood Cells Mol Dis 2017; 67: 81-85
    CrossrefPubMedGoogle Scholar
  • 15 Miesbach W, Alesci S, Krekeler S, Seifried E. Comorbidities and bleeding pattern in elderly haemophilia A patients. Haemophilia 2009; 15 (04) 894-899
    CrossrefPubMedGoogle Scholar
  • 16 Poskitt EM. Defining childhood obesity: the relative body mass index (BMI). European Childhood Obesity group. Acta Paediatr 1995; 84 (08) 961-963
    CrossrefPubMedGoogle Scholar
  • 17 Kromeyer-Hauschild KMA, Wabitsch M. Referenzwerte für den Body-Mass-Index für Kinder, Jugendliche und Erwachsene in Deutschland. Anpassung der AGA-BMI-Referenz im Altersbereich von 15 bis 18 Jahren. Adipositas 2015; 9: 123-127
    PubMedGoogle Scholar
  • 18 Kromeyer-Hauschild KWM, Geller F, Ziegler A. , et al. Perzentile für den Body Mass Index für das Kindes- und Jugendalter unter Heranziehung verschiedener deutscher Stichproben. Monatsschr Kinderheilkd 2001; 149: 807-818
    CrossrefPubMedGoogle Scholar
  • 19 O'Hara J, Hughes D, Camp C, Burke T, Carroll L, Diego DG. The cost of severe haemophilia in Europe: the CHESS study. Orphanet J Rare Dis 2017; 12 (01) 106
    CrossrefPubMedGoogle Scholar
  • 20 Angelini D, Konkle BA, Sood SL. Aging among persons with hemophilia: contemporary concerns. Semin Hematol 2016; 53 (01) 35-39
    CrossrefPubMedGoogle Scholar
  • 21 Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health 2009; 9: 88
    CrossrefPubMedGoogle Scholar
  • 22 Kurth BM, Schaffner Rosario A. Übergewicht und Adipositas bei Kindern und Jugendlichen in Deutschland. Ergebnisse des bundesweiten Kinder- und Jugendgesundgeitssurveys (KIGGS). Bundesgesundgeitsbl 2010; 7/6 (53) 643-652
    PubMedGoogle Scholar
  • 23 García-Dasí M, Torres-Ortuño A, Cid-Sabatel R, Barbero J. Practical aspects of psychological support to the patient with haemophilia from diagnosis in infancy through childhood and adolescence. Haemophilia 2016; 22 (05) e349-e358
    CrossrefPubMedGoogle Scholar
  • 24 Collins PW, Fischer K, Morfini M, Blanchette VS, Björkman S. ; International Prophylaxis Study Group Pharmacokinetics Expert Working Group. Implications of coagulation factor VIII and IX pharmacokinetics in the prophylactic treatment of haemophilia. Haemophilia 2011; 17 (01) 2-10
    CrossrefPubMedGoogle Scholar